Clinical-spectrum validation is needed for cfRNA-based preoperative risk stratification (Letter-to-the-Editor).

Wang T, Tong R, Huang Z

Open source

DOI
10.1016/j.ajog.2026.09.013
Published
2026 Sep 18
Container
American journal of obstetrics and gynecology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ajog.2026.09.013,
  title = {Clinical-spectrum validation is needed for cfRNA-based preoperative risk stratification (Letter-to-the-Editor).},
  author = {Wang T and Tong R and Huang Z},
  year = {2026},
  journal = {American journal of obstetrics and gynecology},
  doi = {10.1016/j.ajog.2026.09.013},
  url = {https://doi.org/10.1016/j.ajog.2026.09.013}
}

RIS

TY  - JOUR
TI  - Clinical-spectrum validation is needed for cfRNA-based preoperative risk stratification (Letter-to-the-Editor).
AU  - Wang T
AU  - Tong R
AU  - Huang Z
PY  - 2026
JO  - American journal of obstetrics and gynecology
DO  - 10.1016/j.ajog.2026.09.013
UR  - https://doi.org/10.1016/j.ajog.2026.09.013
ER  - 

APA

T, W., R, T., & Z, H. (2026). Clinical-spectrum validation is needed for cfRNA-based preoperative risk stratification (Letter-to-the-Editor).. American journal of obstetrics and gynecology. https://doi.org/10.1016/j.ajog.2026.09.013

Source records